We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-1.06%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$481B
AUM Growth
+$34.6B
Cap. Flow
+$38.1B
Cap. Flow %
7.92%
Top 10 Hldgs %
29.35%
Holding
15,428
New
1,885
Increased
5,794
Reduced
5,768
Closed
1,724

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$1.26B
2
MSFT icon
Microsoft
MSFT
+$633M
3
BABA icon
Alibaba
BABA
+$501M
4
ATVI
Activision Blizzard
ATVI
+$484M
5
AAPL icon
Apple
AAPL
+$456M

Sector Composition

Rank Sector Weight
1 Technology 3.08%
2 Consumer Discretionary 2.25%
3 Financials 2.23%
4 Healthcare 2.22%
5 Industrials 1.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APGB.WS
9851
DELISTED
Apollo Strategic Growth Capital II Warrants, each exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share
APGB.WS
$483K ﹤0.01%
518,748
+343,269
+196% +$379K
PSCC icon
9852
Invesco S&P SmallCap Consumer Staples ETF
PSCC
$42M
$482K ﹤0.01%
+14,403
New +$486K
PSFF icon
9853
Pacer Swan SOS Fund of Funds ETF
PSFF
$598M
$482K ﹤0.01%
+21,940
New +$486K
CYT
9854
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
$482K ﹤0.01%
+27,510
New +$514K
OCDX
9855
PUT
DELISTED
Ortho Clinical Diagnostics Holdings plc Ordinary Shares
OCDX
$482K ﹤0.01%
+26,100
New +$526K
ARQQ icon
9856
Arqit Quantum
ARQQ
$424M
$481K ﹤0.01%
+959
New +$477K
ASC icon
9857
Ardmore Shipping
ASC
$719M
$481K ﹤0.01%
115,957
+44,201
+62% +$157K
CUK
9858
CALL
DELISTED
Carnival PLC
CUK
$481K ﹤0.01%
21,100
+7,700
+57% +$163K
GLP icon
9859
Global Partners
GLP
$1.72B
$481K ﹤0.01%
22,688
+8,482
+60% +$191K
KBR icon
9860
PUT
KBR
KBR
$4.84B
$481K ﹤0.01%
12,200
+4,200
+53% +$163K
KRRO icon
9861
CALL
Korro Bio
KRRO
$196M
$481K ﹤0.01%
1,364
-306
-18% -$120K
MEDP icon
9862
Medpace
MEDP
$16.1B
$481K ﹤0.01%
+2,543
New +$464K
MRSN
9863
PUT
DELISTED
Mersana Therapeutics
MRSN
$481K ﹤0.01%
2,040
+1,156
+131% +$338K
SHG icon
9864
Shinhan Financial Group
SHG
$35.4B
$481K ﹤0.01%
14,291
-11,873
-45% -$397K
EVC icon
9865
Entravision Communication
EVC
$832M
$480K ﹤0.01%
67,629
+10,026
+17% +$67.7K
XBAP icon
9866
Innovator US Equity Accelerated 9 Buffer ETF April
XBAP
$133M
$480K ﹤0.01%
18,110
-391,475
-96% -$10.4M
YSG
9867
CALL
Yatsen Holding
YSG
$319M
$480K ﹤0.01%
25,220
-14,520
-37% -$443K
GPP
9868
PUT
DELISTED
Green Plains Partners LP
GPP
$480K ﹤0.01%
36,300
+12,600
+53% +$162K
ECH icon
9869
iShares MSCI Chile ETF
ECH
$1.04B
$479K ﹤0.01%
18,418
+10,904
+145% +$298K
METC icon
9870
Ramaco Resources Class A
METC
$777M
$479K ﹤0.01%
+40,182
New +$334K
CTEV
9871
CALL
Claritev Corp
CTEV
$646M
$479K ﹤0.01%
2,128
-2,457
-54% -$665K
ELVT
9872
DELISTED
Elevate Credit, Inc.
ELVT
$479K ﹤0.01%
115,978
+79,843
+221% +$287K
ZNTE
9873
PUT
DELISTED
Zanite Acquisition Corp. Class A Common Stock
ZNTE
$479K ﹤0.01%
47,400
-18,400
-28% -$185K
KEEL
9874
CALL
Keel Infrastructure Corp
KEEL
$2.17B
$477K ﹤0.01%
+112,200
New +$550K
CTS icon
9875
CTS Corp
CTS
$1.81B
$477K ﹤0.01%
15,457
-35,466
-70% -$1.21M

Similar funds

Ken Griffin's Q3 2021 Portfolio in Review

As of Q3 2021, Ken Griffin held 15,428 positions worth $481B, up 7.8% from $447B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Ken Griffin deployed $38.1B of net new capital in Q3 2021, opening 1,885 new positions and adding to 5,794 existing holdings. Its largest new stake was Etsy: 948,509 shares worth $197M.

By sector, the portfolio is most concentrated in Technology at 3.1% of assets, down from 3.2% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $622M trimmed.

  • Ken Griffin's largest Q3 2021 buy was Etsy: 948,509 shares worth $197M.
  • Ken Griffin added most to Tesla in Q3 2021, an estimated $1.26B increase.
  • Ken Griffin's biggest Q3 2021 reduction was Meta Platforms (Facebook), cutting an estimated $622M.
  • Ken Griffin fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $597M.
  • Ken Griffin's ten largest holdings make up 29% of its $481B portfolio in Q3 2021.
  • Ken Griffin opened 1,885 new positions and closed 1,724 in Q3 2021.
  • Ken Griffin's portfolio value rose 7.8% quarter-over-quarter to $481B.

Based on Citadel Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.